2010年9月考入清华大学生命科学学院，攻读临床医学-药学专业；2014年6月毕业于清华大学药学系，获得理学学士学位

2014年9月考入清华大学药学系，攻读药剂学专业；2017年6月毕业于清华大学药学院，获得医学硕士学位

研究方向：单抗溶液体系的液-液相分离现象与黏度改善

个人邮箱：liqingily@sina.com

发表的学术论文：

Wu G, Wang S, Tian Z, Zhang N, Hu T, Dai W, and Qian F. (2017) Elucidate the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives. Eur J Pharm & Bio. 120(Supplement C), 1-8.

Wang S, Zhang X, Wu G, Tian Z, Li L, Zhao Q, Jiang G, and Qian F. (2017) Formulation optimization of high-concentration endostatin: harmonization of excipients’ contributions on colloidal and conformational stabilities. Int J Pharm. 530(1-2):173-186.

Wang S, Wu G, Zhang X, Tian Z, Zhang N, Hu T, Dai W, and Qian F. (2017) Stabilizing two IgG1 monoclonal antibodies by surfactants: balance between aggregation prevention and structure perturbation. Eur J Pharm &Bio. 114, 263-277.

Liu C, Chen Z, Chen Y, Lu J, Li Y, Wang S, Wu G, & Qian F. (2016). Improving Oral Bioavailability of Sorafenib by Optimizing the "Spring" and "Parachute" Based on Molecular Interaction Mechanisms. Mol Pharm, 13(2), 599-608.

Liu C, Kong C, Wu G, Zhu J, Javid B, & Qian F. (2015). Uniform and amorphous rifampicin microspheres obtained by freezing induced LLPS during lyophilization. Int J Pharm, 495(1), 500-507.

就业去向：

2017年7月-至今，于浙江我武生物科技股份有限公司担任企划专员

主要工作：

新药申请、项目调研、项目评估、环保管理、产品出口、专利写作等